David A. Frye

David Frye practices at Arizona Oncology - HOPD in Tucson, Arizona.

David Frye's NPI, 1750441770, was assigned on December 11, 2006. David Frye graduated from Geisel School Of Medicine At Dartmouth in 1999. David Frye holds Arizona license 37997.

David Frye's primary practice is Arizona Oncology - HOPD, at 6567 E Carondelet Dr, Tucson, AZ 85710.

David Frye's primary practice is Arizona Oncology - HOPD in Tucson, Arizona. David Frye is also affiliated with Tucson Medical Center. The medical group on file is Arizona Oncology. Dmand AI also links David Frye to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. David Frye's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where David Frye practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is David Frye's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. David Frye is board certified in radiation oncology by the American Board of Radiology. Dmand AI has David Frye's licenses on file in 5 states: Arizona, Hawaii, District of Columbia, Maryland and Minnesota.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions David Frye treats.

CMS data shows 2,696 Medicare services from David Frye across 21 procedure codes in 2024, for 194 Medicare patients. Medicare paid $521,579 for them. Every service was in an office.

CMS counts 194 Medicare patients who saw David Frye in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Frye's median patient age at 74, with 48% women.

In 2024, David Frye wrote 247 Medicare Part D claims for 89 patients. 94% of them were for generic drugs. CMS names the drug for 152 of them, across 7 drugs with 11 or more claims each, at $1,963 in total drug cost. In 2023, CMS named 151 claims across 6 drugs.

David Frye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Frye as offering telehealth.

CMS Open Payments shows 79 general payments to David Frye from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. GT Medical Technologies, Inc paid the most, $1,572.

Dmand AI lists 1 award for David Frye, most recently CMS Stage 1 EHR in 2013.

David Frye graduated from Geisel School Of Medicine At Dartmouth in 1999.

David Frye is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.